Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, ca... Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue. Show more
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate PR Newswire BOSTON, Nov. 18, 2024 Ratio to receive upfront, and potential milestones...
Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer PR Newswire EAST HANOVER, N.J., Oct. 18, 2024 If approved...
October 3, 2024 -- InvestorsHub NewsWire -- via NetworkNewsWire Editorial Coverage: Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring...
LEXINGTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that...
Novartis si assicura i diritti esclusivi globali alla tecnologia di microglassification di Lindy Biosciences in diversi target biologici La collaborazione mira a consentire trattamenti...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.82 | -0.786721673223 | 104.23 | 104.68 | 102.4 | 1307045 | 103.20184064 | DR |
| 4 | -10.67 | -9.353085554 | 114.08 | 115.765 | 102.4 | 1367231 | 107.61398053 | DR |
| 12 | -16.68 | -13.8895828129 | 120.09 | 120.92 | 102.4 | 1109557 | 112.55516718 | DR |
| 26 | 0.63 | 0.61295971979 | 102.78 | 120.92 | 98.913 | 1190816 | 110.16507627 | DR |
| 52 | 7.28 | 7.57307812337 | 96.13 | 120.92 | 92.35 | 1345360 | 104.4495539 | DR |
| 156 | 21.69 | 26.5418502203 | 81.72 | 120.92 | 74.09 | 1871333 | 92.45877805 | DR |
| 260 | 13.33 | 14.7979573712 | 90.08 | 120.92 | 69.1 | 1925321 | 90.43100867 | DR |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
